Lv11
50 积分 2022-07-29 加入
BRAF V600突变型非小细胞肺癌的治疗进展
2小时前
已完结
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the (Modern) Treatment of Melanoma
2个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
2个月前
已完结
EP.12.36 Data Visualization of Treatment Patterns in Adults With BRAFV600EMutant mNSCLC in Real-World Settings
2个月前
已关闭
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
2个月前
已完结
Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort
2个月前
已完结
Evaluation on the first 2 years of the positive list system in South Korea
5个月前
已完结
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
5个月前
已完结
A systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury
6个月前
已完结
[Current status of palliative care for patients with unresectable metastatic colorectal cancer in China: a questionnaire-based survey]
8个月前
已完结
皖公网安备34019202002308
